Cost-effective analyses in Breast Cancer Research and Treatment
Terpenoids and breast cancer chemoprevention
Proliferation is the strongest prognosticator in node-negative breast cancer
Fulvestrant for systemic therapy of locally advanced or metastatic breast cancer in postmenopausal women
Cancer stem/progenitor cell active compound 8-quinolinol in combination with paclitaxel achieves an improved cure of breast cancer in the mouse model
Systemic chemokine levels in breast cancer patients and their relationship with circulating menstrual hormones
The androgen metabolite 5α-androstane-3β,17β-diol (3βAdiol) induces breast cancer growth via estrogen receptor
Insulin receptor substrate 1 modulates the transcriptional activity and the stability of androgen receptor in breast cancer cells
No evidence that CDKN1B (p27) polymorphisms modify breast cancer risk in BRCA1 and BRCA2 mutation carriers
Large BRCA1 and BRCA2 genomic rearrangements in Danish high risk breast-ovarian cancer families
Clinicopathological features of the triple-negative tumors in Chinese breast cancer patients
Analysis of chemotherapy-induced amenorrhea rates by three different anthracycline and taxane containing regimens for early breast cancer
Bcl-2 expression predicts local relapse for early-stage breast cancer receiving conserving surgery and radiotherapy
Short-term outcome of primary operated early breast cancer by hormone and HER-2 receptors
Response to neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients
Psychological impact of recall in high-risk breast MRI screening
The Austrian fulvestrant registry
Differences and similarities in breast cancer risk assessment models in clinical practice
CYP2C19*17 is associated with decreased breast cancer risk
BRCA1 promoter methylation is associated with increased mortality among women with breast cancer
High-resolution melting analysis for rapid screening of BRCA1 and BRCA2 Spanish mutations
A retrospective study of quality of life in a community sample of patients with early stage breast cancer
Pattern of metastatic spread in triple-negative breast cancer
The rising incidence of male breast cancer
Dihydrofolate reductase (DHRF) 19-bp intron-1 deletion and methylenetetrahydrofolate reductase (MTHFR) C677T polymorphisms in breast cancer
The sensitivity of BRCA1 mutation carriers to ionising radiation
Link between insulin and metabolic disorders in cancer